S. 1973

Status: In committee

Treat and Reduce Obesity Act of 2025

Treat and Reduce Obesity Act of 2025

Sponsored by Bill Cassidy (Republican-LA)

Topics

Cosponsors

22

Actions

2

Roll calls

0

Amendments

0

Related bills

1

Actions

Jun 5, 2025 · Library of Congress

Introduced in Senate

Jun 5, 2025 · Senate

Read twice and referred to the Committee on Finance.

Latest activity

July 2026

Lobbying reported · Academy of Nutrition and Dietetics · Jul 20

Academy of Nutrition and Dietetics reported 2nd Quarter (Apr 1 - June 30) lobbying for Academy of Nutrition and Dietetics — $154,615

BillsH.R. 3826 H.R. 4206 H.R. 4231 H.R. 5731 H.R. 5753 H.R. 6199 S. 1261 S. 1925 S. 1973 S. 3934

Lobbying reported · America's Health Insurance Plans (ahip) · Jul 20

America's Health Insurance Plans (ahip) reported 2nd Quarter (Apr 1 - June 30) lobbying for America's Health Insurance Plans (ahip) — $3,010,000

BillsH.R. 1 H.R. 247 H.R. 379 H.R. 584 H.R. 608 H.R. 610 H.R. 842 H.R. 935 H.R. 950 H.R. 957 H.R. 1096 H.R. 1117 H.R. 1157 H.R. 1162 H.R. 1397 H.R. 1403 H.R. 1523 H.R. 1614 H.R. 1627 H.R. 1775 H.R. 1776 H.R. 1805 H.R. 1867 H.R. 1899 H.R. 1924 H.R. 2013 H.R. 2045 H.R. 2049 H.R. 2079 H.R. 2199 H.R. 2309 H.R. 2433 H.R. 2450 H.R. 2528 H.R. 2533 H.R. 2553 H.R. 2554 H.R. 2571 H.R. 2586 H.R. 2610 H.R. 2636 H.R. 2741 H.R. 3000 H.R. 3023 H.R. 3069 H.R. 3415 H.R. 3493 H.R. 3527 H.R. 3546 H.R. 3701 H.R. 3789 H.R. 3808 H.R. 4093 H.R. 4206 H.R. 4231 H.R. 4313 H.R. 4317 H.R. 4406 H.R. 4559 H.R. 4605 H.R. 4623 H.R. 4641 H.R. 4710 H.R. 5081 H.R. 5145 H.R. 5243 H.R. 5281 H.R. 5371 H.R. 5509 H.R. 5526 H.R. 5582 H.R. 5584 H.R. 6010 H.R. 6232 H.R. 6248 H.R. 6255 H.R. 6361 H.R. 6703 H.R. 6951 H.R. 6974 H.R. 7023 H.R. 7064 H.R. 7164 H.R. 7189 H.R. 7409 H.R. 7537 H.R. 7727 H.R. 7778 H.R. 7787 H.R. 7790 H.R. 7803 H.R. 7837 H.R. 7871 H.R. 8270 H.R. 8375 H.R. 8377 H.R. 8684 H.R. 8779 H.R. 8875 H.R. 9393 H.R. 9504 S. 339 S. 483 S. 526 S. 529 S. 652 S. 717 S. 729 S. 752 S. 864 S. 882 S. 891 S. 931 S. 939 S. 976 S. 1040 S. 1041 S. 1056 S. 1082 S. 1096 S. 1227 S. 1261 S. 1414 S. 1637 S. 1753 S. 1816 S. 1818 S. 1847 S. 1954 S. 1973 S. 2237 S. 2289 S. 2345 S. 2355 S. 2356 S. 2497 S. 2556 S. 2620 S. 2658 S. 2709 S. 2903 S. 3014 S. 3599 S. 3642 S. 3690 S. 3727 S. 3729 S. 3750 S. 3751 S. 3762 S. 3822 S. 3829 S. 3834 S. 3848 S. 3886 S. 3990 S. 4189 S. 4332 S. 4355 S. 4384 S. 4509 S. 4512

Lobbying reported · Forbes-Tate · Jul 20

Forbes-Tate reported 2nd Quarter (Apr 1 - June 30) lobbying for Eli Lilly and — $50,000

BillsH.R. 4231 H.R. 5316 H.R. 6509 S. 1973 S. 3794

Lobbying reported · Alliance for Patient Access · Jul 20

Alliance for Patient Access reported 2nd Quarter (Apr 1 - June 30) lobbying for Alliance for Patient Access — $20,000

BillsH.R. 3267 H.R. 4231 H.R. 4317 H.R. 6423 S. 864 S. 1973 S. 3267

Lobbying reported · Dla Piper LLP (US) · Jul 20

Dla Piper LLP (US) reported 2nd Quarter (Apr 1 - June 30) lobbying for Currax Pharmaceuticals — $50,000

BillsH.R. 4231 S. 1973

Lobbying reported · Arnold & Porter Kaye Scholer · Jul 17

Arnold & Porter Kaye Scholer reported 2nd Quarter (Apr 1 - June 30) lobbying for Novo Nordisk — $70,000

BillsH.R. 4231 S. 1973

You’re all caught up.